A Study Of Minimally Invasive SpeedBridge For Insertional Achilles Tedinosis

Overview

About this study

The purpose of this study is to compare clinical, functional, radiographic, and complication outcomes following endoscopic-assisted versus non-endoscopic minimally invasive SpeedBridge repair for chronic insertional Achilles tendinosis that has failed at least six months of conservative treatment

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Age ≥ 18 years

  • Evidence of insertional Achilles tendinosis on imaging and on clinical exam

  • Chronicity defined by failing 6 months of conservative management

  • Scheduled for a primary MIS SpeedBridge procedure without a gastrocnemius recession

 

Exclusion Criteria:

  • Prior Achilles surgery or prior incision in the operative region

  • Revision procedures

  • Worker’s compensation patients

  • Concomitant gastrocnemius recession

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 07/23/2026. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Jacksonville, Fla.

Mayo Clinic principal investigator

Contact us for the latest status

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions